Genetic variation in toll-like receptor signalling and the risk of inflammatory and immune diseases

Journal of Innate Immunity

Volumn 1, Issue 4, 2009, Pages 350-357

  Corr, Sinead C ^a   O'Neill, Luke A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Genetic variation; IRAK4; MyD88 adapter like; Toll like receptor

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; TOLL LIKE RECEPTOR;

ASTHMA; ATHEROSCLEROSIS; BACTERIAL INFECTION; ENTERITIS; GASTRITIS; GENETIC VARIABILITY; HEREDITY; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; MALARIA; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SEPSIS; STOMACH CANCER; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOSIS;

ANIMALS; FEMALE; GENETIC VARIATION; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNITY, INNATE; INFLAMMATION; MALE; MICE; TOLL-LIKE RECEPTORS;

EID: 77953444175     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000200774     Document Type: Review

References (62)

1. Browning BL, Huebner C, Petermann I, Gearry RB, Barclay ML, Shelling AN, Ferguson LR: Has Toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol 2007; 102:2504-2512.
2. Rallabhandi P, Bell J, Boukhvalova MS, Med-vedev A, Lorenz E, Arditi M, Hemming VG et al: Analysis of TLR4 polymorphic variants: new insights into TLR4/MD2/CD14 stoichiometry, structure and signalling. J Immunol 2006; 177:322-332.
3. De Jager PL, Franchimont D, Waliszewska A, Bitton A, Cohen A, Langelier D, Belaiche J, et al: The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun 2007; 8:387-397.
4. Gazuoli M, Mantzaris, G, Kotsinas, A, Za-charatos P, Papalambros E, Archimandritis A, Ikonomopoulos J, et al: Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 2005; 11: 681-685.
5. Wang F, Tahara, T, Arisawa T, Shibata T, Na-kamura M, Fujita H, Iwata M, et al: Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis. J Gastroenterol Hepatol 2007; 22: 925- 929.
6. Hong J, Leung E, Fraser AG, Merriman TR, Vishnu P, Krissansen GW: TLR2, TLR4, TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian population. J Gastroenterol Hepatol 2007;22:1760-1766.
7. Kunitomo M: Oxidative stress and Atherosclerosis. Yakugaku Zasshi 2007; 127: 19 97- 2014.
8. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA: Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347:185-192.
9. Ballantyne CM, Entman ML: Soluble adhesion molecules and the search for biomarkers for atherosclerosis. Circulation 2002;106: 766-767.
10. Hommels MJ, Kroon AA, Netea MG, De Leeuw PW, Bruggemann CA, Leiner T, Koster DA, et al: The Asp299Gly Toll-like receptor 4 polymorphism in advanced aortic artherosclerosis. Neth J Med 2007;65:203- 207.
11. Beisswenger C, Bals R: Interaction of allergies airway inflammation and innate immunity: hygiene and beyond. J Occup Med Toxicol 2008; 3(suppl 1):S3.
12. Von Mutius E, Braun-Fahrlander C, Schierl R, Riedler J, Ehlermann S, Maisch S, Waser M, Nowak D: Exposure to endotoxin or other bacterial components might protect gainst the development of atopy. Clin Exp Allergy 2000; 30: 1230-1234.
13. Riedler J, Braun-Fahrlander C, Eder W, Schreuer M, Waser M, Maisch S, Carr D, Schierl R, et al: Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001;358: 1129-1133.
14. Eder W, Klimecki W, Yu L, Von Mutius E, Riedler J, Braun-Fahrlander C, Nowak D, et al: Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004;113:482-488.
15. Werner M, Topp R, Wimmer K, Richter K, Bischof W, Wjst M, Heinrich J: TLR4 gene variants modify endotoxin effects on asthma. J Allergy Clin Immunol 2003;112:323- 330.
16. Lachheb J, Dhifallah IB, Chelbi H, Hamzaoui K, Hamzaoui A: Toll-like receptors and CD14 genes polymorphisms and susceptibility to asthma in Tunisian children. Tissue Antigens 2008; 71: 417-425.
17. Noguchi E, Nishimura F, Fukai H, Kim J, Ichikawa K, Shibasaki M, Arinami T: An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 2004;34:177-183.
18. Balaci L, Spada MC, Olla N, Sole G, Loddo L, Anedda F, Naitza S, et al: IRAK-M is involved in the pathogenesis of early-onset persistant asthma. Am J Hum Genet 2007; 80:1103 -1114.
19. Reindl M, Lutterotti A, Ingram J, Schanda K, Gassner C, Deisenhammer F, Berger T, Lorenz E: Mutations in the gene for toll-like receptor 4 and multiple sclerosis. Tissue Antigens 2003; 61: 85-88.
20. Kroner A, Vogel F, Kolb-Maurer A, Kruse N, Toyka KV, Hemmer B, Rieckmann P, Maurer M: Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr4) gene on disease course of multiple sclerosis. J Neuroim-munol 2005;165:161-165.
21. Urcelay E, Blanco-Kelly F, De las Heras V, De la Concha EG, Arroya R, Martinez A: TLR4 haplotypes in multiple sclerosis: a case-control study in the Spanish population. J Neuroimmunol 2007;192:215-218.
22. Marta M, Andersson A, Isaksson M, Kampe O, Lobell A: Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. Eur J Immunol 2008; 38:565-575.
23. Radstake TR, Franke B, Hanssen S, Netea MG, Welsing P, Barrera P, Joosten PA, et al: The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum 2004; 50: 999-1007.
24. Kilding R, Akil M, Till S, Amos R, Winfield J, Iles MM, Wilson AG: A biologically important single nucleotide polymorphism within the toll-like receptor-4 gene is not associated with rheumatoid arthritis. Clin Exp Rheumatol 2003;21:340-342.
25. Sanchez E, Orozco G, Lopez-Nevot MA, Ji-menez-Alonso J, Martin J: Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythema-tosus. Tissue Antigens 2004;63:54-57.
26. Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, et al: Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Expt Med 2005;202:1131-1139.
27. Sheedy FJ, Marinou I, O'Neill LA, Wi lson AG: The Mal/TIRAP S180L and TLR4 G299D polymorphisms are not associated with susceptibility to or severity of rheumatoid arthritis. Ann Rheum Dis 2008;67:1328-1331.
28. Anders HJ: A Toll for lupus. Lupus 2005; 14: 417-422.
29. Christensen SR, Kashgarian M, Alexopou-lou L, Flavell RA, Akira S, Shlomchik MJ: Toll-like receptor 9 controls anti-DNA auto-antibody production in murine lupus. J Exp Med 2005;202:321-331.
30. Lenert PS: Targeting Toll-like receptor signalling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus. Arthritis Res Ther 2006;8:203.
31. Bhattacharjee RN, Akira S: Modifying tolllike receptor 9 signalling for therapeutic use. Mini Rev Med Chem 2006;6:287-291.
32. Hur JW, Shin HD, Park BL, Kim LH, Kim SY, Bae SC: Association study of Toll-like receptor 9 gene polymorphisms in Korean patients with systemic lupus erythematosus. Tissue Antigens 2005;65:266-270.
33. Demirci FY, Manzi S, Ramsey-Goldman R, Kenney M, Shaw PS, Dunlop-Thomas CM, Kao AH, et al: Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus. J Rheumatol 2007; 34:1708- 1711.
34. Castiblanco J, Varela DC, Castano-Ro-driquez N, Rojas-Villarraga A, Hincapie ME, Anaya JM: TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. Infect Genet Evol 2008;8: 541-544.
35. Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, Frodsham AJ, et al: A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 2007;39:523-528.
36. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.
37. Lorenz E, Mira J, Frees K, Schwartz D: Rel-evance of mutations in the TLR4 receptor in patients with Gram negative septic shock. Arch Int Med 2002;162:1028-1032.
38. Yoon HJ, Choi JY, Kim CO, Park YS, Kim MS, Kim YK, Shin SY, et al: Lack of toll-like receptor 4 and 2 polymorphisms in Korean patients with bacteremia. J Korean Med Sci 2006;21:979-982.
39. Feterowski C, Emmanuilidis K, Miethke T, Gerauer K, Rump M, Ulm K, Holzmann B, Weighardt H: Effects of functional toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology 2003;109:426-431.
40. Stevenson MM, Riley EM: Innate immunity to malaria. Nat Rev Immunol 2004;4: 169 -180.
41. Mockenhaupt FP, Cramer JP, Hamann L, Stegemann MS, Eckert J, Oh NR, Otchwemah RN, Dietz E, et al: Toll-like receptor (TLR) poly morphisms in African children: common TLR4 variants predispose to severe malaria. Proc Natl Acad Sci USA 2006; 103: 177-182.
42. Centers for Disease Control: Fact Sheet: Tuberculosis in the United States. Atlanta, Centers for Disease Control, 2005.
43. Quesniaux V, Fremond C, Jacobs M, Parida S, Nicolle D, Yeremeev V, Bihl F, et al: Tolllike receptor pathways in the immune responses to mycobacteria. Microbes Infect 2004; 6:946-959.
44. Ferwerda G, Kullberg BJ, de Jong DJ, Girardin SE, Langenberg DM, van Crevel R, Ottenhoff TH, et al: Mycobacterium paratuberculosis is recognised by Toll-like receptors and NOD2. J Leukoc Biol 2007; 82:1011-1018 .
45. Ogus AC, Yoldas B, Ozdemir T, Uguz A, Ol-cen S, Keser I, Coskun M, et al: The Arg-753Gln polymorphism of the human Tolllike receptor 2 gene in tuberculosis disease. Eur Respir J 2004;23:219-223.
46. Newport MJ, Allen A, Awomoyi AA, Dun-stan SJ, McKinney E, Marchant A, Sirugo G: The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in the Ga mbia. Tuberculosis 2004; 84: 347-352.
47. Ma X, Liu Y, Gowen BB, Graviss EA, Clark AG, Musser JM: Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS ONE 2007; 2:e1318.
48. Ozinsky A, Underhill DM, Fontenot JD, Haj-jar AM, Smith KD, Wilson CB, Schroeder L, Aderem A: The repertoire of pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000;97:13766-13771.
49. Nejentsev S, Thye T, Szeszko JS, Stevens H, Balabanova Y, Chinbuah AM, Hibberd M, et al: Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations. Nat Genet 2008; 40:261-262.
50. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ, Skerrett SJ, et al: A common dominant TLR5 stop codon polymorphism abolishes flagellin signalling and is associated with susceptibility to Legionnaires disease. J Exp Med 2003;198: 1563 -1572.
51. Picard C, Von Bernuth H, Ku CL, Yang K, Puel A, Casanova JL: Inherited human IRAK-4 deficiency: an update. Immunol Res 2007;38:347-352.
52. Johnson CM, Lyle EA, Omueti KO, Stepen-sky VA, Yegin O, Alpsoy E, Hamann L, et al: Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 2007;178:7520-7524.
53. Tabel Y, Berdeli A, Mir S: Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children. Int J Im-munogenet 2007; 34:399-405.
54. El-Omar EM, Ng Mt, Hold GL: Polymorphisms in toll-like receptor genes and risk of cancer. Oncogene 20 08; 27: 244-252.
55. Alvarez-Arellano L, Camorlinga-Ponce M, Ma ldonado-Berna l C, Torres J: Activat ion of human neutrophils by Helicobacter pylori and the role of toll-like receptors 2 and 4 in the response. FEMS Immunol Med Micro-biol 2007; 51: 473-479.
56. Achyut BR, Goshal UC, Moorchung N, Mit-tal B: Association of Toll-like receptor 4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. Hum Immunol 2007; 68: 901-907.
57. Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA, Vaughan TL, et al: A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007;132:905-912.
58. Tahara T, Arisawa T, Wang F, Shibata T, Na-kamura M, Sakata M, Hirata I, Nakano H: Toll-like receptor 2 (TLR)-196 to 174del polymorphism in gastro-duodenal diseases in Japanese population. Dig Dis Sci 2008;53: 919 -924 .
59. Zheng SL, Augustsson-Balter K, Chang B, Hedelin M, Li L, Adami HO, Bensen J, Li G, Johnasson JE, et al: Sequence variants of Toll-like receptor 4 are associated with prostate cancer risk: results from the cancer prostate in Sweden study. Cancer Res 2004; 64: 2918-2922.
60. Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ: Sequence variants of toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 2005; 65:11771- 11778.
61. Sun J, Wikland F, Zheng LS, Chang B, Balter K, Li L, Johansson JE, et al: Sequence variants in toll-like receptor gene cluster (TLR6-TL R1-TL R10) and prostate cancerrisk. J Nat l Cancer Inst 2007;97:525-532.
62. Chen YC, Giovannucci E, Kraft P, Lazarus R, Hunter DJ: Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. Cancer Epidemiol Bio-markers Prev 2007;16:1982-1989.